CO4970719A1 - Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria - Google Patents

Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria

Info

Publication number
CO4970719A1
CO4970719A1 CO98051488A CO98051488A CO4970719A1 CO 4970719 A1 CO4970719 A1 CO 4970719A1 CO 98051488 A CO98051488 A CO 98051488A CO 98051488 A CO98051488 A CO 98051488A CO 4970719 A1 CO4970719 A1 CO 4970719A1
Authority
CO
Colombia
Prior art keywords
alkyl
carbon atoms
optionally substituted
halogen
groups
Prior art date
Application number
CO98051488A
Other languages
English (en)
Inventor
Geoffrey Duke Edward Clarke
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719183.7A external-priority patent/GB9719183D0/en
Priority claimed from GBGB9719189.4A external-priority patent/GB9719189D0/en
Priority claimed from GBGB9719290.0A external-priority patent/GB9719290D0/en
Priority claimed from GBGB9803611.4A external-priority patent/GB9803611D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CO4970719A1 publication Critical patent/CO4970719A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Un compuesto de la fórmula (I)(estereoquímica relativa indicada)en donde: R1 representa alquilo de 1 a 6 átomos de carbono; R2 representa alquilo de 2 a 4 átomos de carbono o alquenilo de 2 a 4 átomos de carbono; X representa CO o SO2 ; Het representa un sistema de anillo aromáticomonocíclico o bicíclico de 5 a 10 elementos, opcionalmente substituido, que contiene 1 a 4 heteroátomos seleccionados de O, N, y S; n representa un número entero de 0 a 4; R3 y R4 representan independientemente hidrógeno, alquilo de 1 a 8 átomos de carbono, -(CH2 )1-4 CONR5 R6 , COC1-4 alquilo o(CH2 )0-2 Fen en donde Fen representa fenilo opcionalmente sustituido por uno o más grupos alquilo de 1 a 4 átomos de carbono o grupos halógeno o NR3 R4 juntos representan azetidinilo, pirrolidinilo, piperidinilo, azepinilo, morfolinilo, piperazinilo opcionalmente N-susbtituido por alquilo de 1 a 6 átomos de carbono, fenilo(opcionalmente substituido por halógeno o alquilo de 1 a 4 átomos de carbono) o bencilo (opcionalmente substituido en el anillo de benceno por halógeno o alquilo de 1 a 4 átomos de carbono) o NR3 R4 juntos representan un anillo como se ha descrito hasta ahora salvo que se substituye en el carbono por uno o más grupos alquilo de 1 a 4 átomos de carbono, CONR5 R6 o COOR6 . R5 y R6 representan independientemente hidrógeno o alquilo de 1 a 4 átomos de carbono; y sales y solvatos de los mismos.
CO98051488A 1997-09-09 1998-09-08 Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria CO4970719A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9719183.7A GB9719183D0 (en) 1997-09-09 1997-09-09 Compounds
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
GBGB9719290.0A GB9719290D0 (en) 1997-09-10 1997-09-10 Compounds
GBGB9803611.4A GB9803611D0 (en) 1998-02-21 1998-02-21 Compounds

Publications (1)

Publication Number Publication Date
CO4970719A1 true CO4970719A1 (es) 2000-11-07

Family

ID=27451698

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98051488A CO4970719A1 (es) 1997-09-09 1998-09-08 Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria

Country Status (24)

Country Link
EP (1) EP1003748A2 (es)
JP (1) JP2001515904A (es)
KR (1) KR20010023766A (es)
CN (1) CN1278820A (es)
AP (1) AP2000001761A0 (es)
AR (1) AR017072A1 (es)
AU (1) AU9741298A (es)
BR (1) BR9812062A (es)
CA (1) CA2303176A1 (es)
CO (1) CO4970719A1 (es)
EA (1) EA200000204A1 (es)
EE (1) EE200000138A (es)
HU (1) HUP0004644A3 (es)
ID (1) ID24452A (es)
IL (1) IL134791A0 (es)
IS (1) IS5391A (es)
MA (1) MA26543A1 (es)
NO (1) NO20001198L (es)
NZ (1) NZ503130A (es)
PE (1) PE107899A1 (es)
PL (1) PL339176A1 (es)
SK (1) SK3192000A3 (es)
TR (1) TR200000907T2 (es)
WO (1) WO1999012933A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
JP2007531755A (ja) 2004-03-31 2007-11-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 非イミダゾール系複素環式化合物
DE102004024772A1 (de) * 2004-05-17 2005-12-22 Grünenthal GmbH Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide
TWI355380B (en) * 2004-05-27 2012-01-01 Nihon Nohyaku Co Ltd Substituted pyrazinecarboxanilide derivatives or s
JP4853759B2 (ja) * 2004-05-27 2012-01-11 日本農薬株式会社 置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
KR20070084455A (ko) 2004-11-23 2007-08-24 워너-램버트 캄파니 엘엘씨 지질혈증 치료용 hmg co-a 환원효소 억제제로서의7-(2h-피라졸-3-일)-3,5-디히드록시-헵탄산 유도체
MX2008013996A (es) 2006-05-04 2009-01-14 Argenta Discovery Ltd Tetrahidropirrolopirimidindionas y su uso como inhibidores de elastasa de neutrofilo humano.
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
WO2009060206A1 (en) * 2007-11-07 2009-05-14 Argenta Discovery Limited 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
CN114650819A (zh) 2019-09-17 2022-06-21 美莱奥生物制药第四有限公司 用于治疗移植物排斥、闭塞性细支气管炎综合征和移植物抗宿主病的阿维来司他
PT4106757T (pt) 2020-04-16 2023-11-17 Mereo Biopharma 5 Inc Métodos que envolvem o inibidor da elastase neutrofílica alvelestat para o tratamento de doenças respiratórias mediadas pela deficiência de alfa 1 antitripsina
TW202325294A (zh) 2021-10-20 2023-07-01 英商梅瑞奧生物製藥4有限公司 用於治療纖維化之嗜中性球彈性蛋白酶抑制劑

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
TR199801935T2 (xx) * 1996-03-28 1999-03-22 Glaxo Group Limited N�trofil elastaz inhibit�rleri olarak pirolopirolon t�revleri.

Also Published As

Publication number Publication date
EA200000204A1 (ru) 2000-10-30
TR200000907T2 (tr) 2000-11-21
EE200000138A (et) 2001-02-15
SK3192000A3 (en) 2001-03-12
WO1999012933A3 (en) 1999-05-27
PL339176A1 (en) 2000-12-04
CN1278820A (zh) 2001-01-03
HUP0004644A2 (hu) 2001-09-28
MA26543A1 (fr) 2004-12-20
NZ503130A (en) 2001-08-31
WO1999012933A2 (en) 1999-03-18
IS5391A (is) 2000-02-29
NO20001198D0 (no) 2000-03-08
HUP0004644A3 (en) 2002-01-28
EP1003748A2 (en) 2000-05-31
BR9812062A (pt) 2000-09-26
CA2303176A1 (en) 1999-03-18
ID24452A (id) 2000-07-20
AU9741298A (en) 1999-03-29
PE107899A1 (es) 1999-11-17
AR017072A1 (es) 2001-08-22
IL134791A0 (en) 2001-04-30
JP2001515904A (ja) 2001-09-25
NO20001198L (no) 2000-05-08
AP2000001761A0 (en) 2000-03-31
KR20010023766A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
CO4970719A1 (es) Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
AR050917A1 (es) Compuestos basados en 2-amido-tiazol que presentan actividad inhibidora de enzimas que utilizan atp, y composiciones y usos de los mismos
AR002746A1 (es) Compuestos derivados de pirimidina condensados con un anillo heterociclico y composicion farmaceutica conteniendo dichos compuestos.
AR010331A1 (es) Compuestos derivados de 6-fenilpiridil-2-amina utiles como inhibidores nos, composiciones farmaceuticas que comprenden dichos compuestos, y metodosde tratamiento utilizando dichos compuestos.
ES2195382T3 (es) Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.
CO5011090A1 (es) Derivados de acil-piperazinil-pirimidinas, procedimiento para su preparacion y composiciones farmaceuticas de los mismos
MX9306227A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
UY25211A1 (es) Inhibidores de isoquinolinilguanidina uroquinasa
MX9806246A (es) PIPERIDINAS NOVEDOSAS DERIVADAS DE 1-/(PIPERAZIN-1-IL)ARIL-(OXI/AMINO)CARBONIL(4-ARIL-PIPERIDIN A COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR 5-HT-1D- beta-.
ES2119326T3 (es) Compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ATE218329T1 (de) Anthracyclinon-derivate und ihre verwendung in amyloidose
DK190188A (da) Aromatiske derivater og fremgangsmaade til fremstilling deraf samt deres anvendelse som antimikrobielle midler
FI800224A (fi) 2-hydroxi-naftalinderivat och anvaendningen av dessa som kopplingskomponenter i diazotypiefieringsmaterial
AR012730A1 (es) Compuestos derivados de aminocicloalquilpirrolidina sustituida cis-sustituidos, droga, agente antimicrobiano y compuesto intermediario
HUP0003455A2 (hu) Benzoxazin- és benzotiazinszármazékok és gyógyszerekben történő alkalmazásuk
DK0873993T3 (da) Hidtil ukendte heterocykliske forbindelser, fremgangsmåde til deres fremstilling og sammensætninger indeholdende dem
ZA802019B (en) Agents for combating pests
SE7712733L (sv) Substituerade o-fenylendiaminderivat, sett for framstellning samt anvendning derav som lekemedel
NO982549L (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
DK0985665T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-oxo-pyrrolidiner, mellemprodukter og anvendelse af disse
NZ335975A (en) Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases
NO955071D0 (no) abeo-Ergolin-derivater som 5HT1A-ligander
BR9812928A (pt) Novos derivados de 3-oxo-(2h) -1,2,4-triazina, processo de preparação de compostos quìmicos, e, composição farmacêutica
ATE72925T1 (de) Synergistische herbizide mischung auf der basis von bifenox und metsulfuron-methyl.
DK0532725T3 (da) Isoxazolderivater som lysfilterpræparater